Viewing Company
Company Name:
MOOLEC SCIENCE SA
CIK:
1937737
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2023-04-03
Last Filing Date:
2025-04-16
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2022-07-01 | 2023-03-31 | CY2023Q1I | 2023-07-10 | 0001213900-23-055654 | $ 753,929 | View |
| 2022-07-01 | 2023-06-30 | None | 2023-10-30 | 0001213900-23-081591 | $ 37,563,768 | View |
| 2022-07-01 | 2023-06-30 | CY2023Q2I | 2023-11-02 | 0001213900-23-082664 | $ 37,563,768 | View |
| 2023-07-01 | 2023-09-30 | CY2023Q3 | 2024-01-22 | 0001213900-24-005272 | $ 265,745 | View |
| 2024-10-01 | 2024-12-31 | CY2024Q4I | 2025-04-16 | 0001213900-25-032538 | $ 1,232 | View |
| 2021-01-01 | 2022-12-31 | CY2022Q4I | 2023-04-03 | 0001213900-23-025842 | $ 0 | View |
| 2023-07-01 | 2024-06-30 | CY2024Q2I | 2024-10-30 | 0001213900-24-092168 | $ 38,440,602 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Financial Instrument Subject to Mandatory Redemption, Par Value Per Share | Par value per share of mandatory redeemable financial instrument classified as liability. | View |
| us-gaap | Business Acquisition, Pro Forma Revenue | The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. | View |
| ifrs-full | 765926 | None | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |